Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 3

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 3

Conditions

Urinary Bladder Neoplasms 20Non-Muscle Invasive Bladder Neoplasms 3Hematuria 3Pain 2Carcinoma in Situ 2Urinary Bladder Neck Obstruction 1Urinary Bladder Diseases 1Urinary Bladder Calculi 1Ureteral Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Nephrolithiasis 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Lower Urinary Tract Symptoms 1Kidney Diseases 1Carcinoma, Transitional Cell 1Anxiety Disorders 1

Interventions

Gemcitabine 30Mitomycin 25BCG Vaccine 11Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5Radiotherapy 5dodecyl maltoside 4apaziquone 4tislelizumab 3Cystoscopy 3ALT-803 3viscum album peptide 2pembrolizumab 2disitamab vedotin 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 25-aminolevulinic acid hexyl ester 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1monalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Non-Muscle Invasive Bladder Neoplasms × Cystoscopy × Clear all
NCT05796375 2026-05-04

ReplaceCysto

White River Junction Veterans Affairs Medical Center

Phase 2 Recruiting
240 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT07000084 2026-04-07

GAIN-BCG

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
330 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic

Phase 1/2 Recruiting
40 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡